Fresenius Medical Care AG (FMS) Form 6-K — Aug 3, 2026
Fresenius Medical Care reported second quarter 2026 operating income excluding special items of EUR 569 million, significantly exceeding market expectations of EUR 515 million. This represents a 23% increase at constant currency compared to the prior year, driven by stronger than expected growth in the Care Delivery segment. Group revenue for the quarter increased by 4% at constant currency to EUR 4,861 million, slightly topping consensus estimates of EUR 4,792 million.
Key figures
- Revenue
- EUR 4,861 million
- Revenue Yoy
- 4%
- Consensus Revenue
- EUR 4,792 million
- Operating Income Growth
- 23%
- Consensus Operating Income
- EUR 515 million
- Operating Income Ex Special Items
- EUR 569 million
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.